help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gilbert, L.
Right arrow Articles by Nanes, M. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gilbert, L.
Right arrow Articles by Nanes, M. S.
Endocrinology Vol. 141, No. 11 3956-3964
Copyright © 2000 by The Endocrine Society

ARTICLES

Inhibition of Osteoblast Differentiation by Tumor Necrosis Factor-{alpha}1

Linda Gilbert, Xiaofei He, Paul Farmer, Scott Boden, Mirek Kozlowski, Janet Rubin and Mark S. Nanes

Division of Endocrinology and Metabolism (L.G., X.H., P.F., M.K., J.R., M.S.N.), Department of Medicine and Department of Orthopedics (S.B.), Emory University School of Medicine and Veterans Affairs Medical Center, Atlanta, Georgia 30033

Address all correspondence and requests for reprints to: Mark S. Nanes, M.D., Ph.D., VA Medical Center (mail code 111), 1670 Clairmont Road, Decatur, Georgia 30033. E-mail: mnanes{at}emory.edu

Tumor necrosis factor-{alpha} (TNF-{alpha}) has a key role in skeletal disease in which it promotes reduced bone formation by mature osteoblasts and increased osteoclastic resorption. Here we show that TNF inhibits differentiation of osteoblasts from precursor cells. TNF-{alpha} treatment of fetal calvaria precursor cells, which spontaneously differentiate to the osteoblast phenotype over 21 days, inhibited differentiation as shown by reduced formation of multilayered, mineralizing nodules and decreased secretion of the skeletal-specific matrix protein osteocalcin. The effect of TNF was dose dependent with an IC50 of 0.6 ng/ml, indicating a high sensitivity of these precursor cells. Addition of TNF-{alpha} from days 2–21, 2–14, 7–14, and 7–10 inhibited nodule formation but addition of TNF after day 14 had no effect. Partial inhibition of differentiation was observed with addition of TNF on only days 7–8, suggesting that TNF could act during a critical period of phenotype selection. Growth of cells on collagen-coated plates did not prevent TNF inhibition of differentiation, suggesting that inhibition of collagen deposition into matrix by proliferating cells could not, alone, explain the effect of TNF. Northern analysis revealed that TNF inhibited the expression of insulin-like growth factor I (IGF-I). TNF had no effect on expression of the osteogenic bone morphogenic proteins (BMPs-2, -4, and -6), or skeletal LIM protein (LMP-1), as determined by semiquantitative RT-PCR. Addition of IGF-I or BMP-6 to fetal calvaria precursor cell cultures enhanced differentiation but could not overcome TNF inhibition, suggesting that TNF acted downstream of these proteins in the differentiation pathway. The clonal osteoblastic cell line, MC3T3-E1–14, which acquires the osteoblast phenotype spontaneously in postconfluent culture, was also studied. TNF inhibited differentiation of MC3T3-E1–14 cells as shown by failure of mineralized matrix formation in the presence of calcium and phosphate. TNF was not cytotoxic to either cell type as shown by continued attachment and metabolism in culture, trypan blue exclusion, and Alamar Blue cytotoxicity assay. These results demonstrate that TNF-{alpha} is a potent inhibitor of osteoblast differentiation and suggest that TNF acts distal to IGF-I, BMPs, and LMP-1 in the progression toward the osteoblast phenotype.




This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
R. Guo, M. Yamashita, Q. Zhang, Q. Zhou, D. Chen, D. G. Reynolds, H. A. Awad, L. Yanoso, L. Zhao, E. M. Schwarz, et al.
Ubiquitin Ligase Smurf1 Mediates Tumor Necrosis Factor-induced Systemic Bone Loss by Promoting Proteasomal Degradation of Bone Morphogenetic Signaling Proteins
J. Biol. Chem., August 22, 2008; 283(34): 23084 - 23092.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
J. Lorenzo, M. Horowitz, and Y. Choi
Osteoimmunology: Interactions of the Bone and Immune System
Endocr. Rev., June 1, 2008; 29(4): 403 - 440.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
X. Baraliakos, J. Listing, J. Brandt, H. Haibel, M. Rudwaleit, J. Sieper, and J. Braun
Radiographic progression in patients with ankylosing spondylitis after 4 yrs of treatment with the anti-TNF-{alpha} antibody infliximab
Rheumatology, September 1, 2007; 46(9): 1450 - 1453.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
X. Lu, L. Gilbert, X. He, J. Rubin, and M. S. Nanes
Transcriptional Regulation of the Osterix (Osx, Sp7) Promoter by Tumor Necrosis Factor Identifies Disparate Effects of Mitogen-activated Protein Kinase and NF{kappa}B Pathways
J. Biol. Chem., March 10, 2006; 281(10): 6297 - 6306.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
H. Kaneki, R. Guo, D. Chen, Z. Yao, E. M. Schwarz, Y. E. Zhang, B. F. Boyce, and L. Xing
Tumor Necrosis Factor Promotes Runx2 Degradation through Up-regulation of Smurf1 and Smurf2 in Osteoblasts
J. Biol. Chem., February 17, 2006; 281(7): 4326 - 4333.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
L. C. Gilbert, J. Rubin, and M. S. Nanes
The p55 TNF receptor mediates TNF inhibition of osteoblast differentiation independently of apoptosis
Am J Physiol Endocrinol Metab, May 1, 2005; 288(5): E1011 - E1018.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
K. Redlich, B. Gortz, S. Hayer, J. Zwerina, N. Doerr, P. Kostenuik, H. Bergmeister, G. Kollias, G. Steiner, J. S. Smolen, et al.
Repair of Local Bone Erosions and Reversal of Systemic Bone Loss Upon Therapy with Anti-Tumor Necrosis Factor in Combination with Osteoprotegerin or Parathyroid Hormone in Tumor Necrosis Factor-Mediated Arthritis
Am. J. Pathol., February 1, 2004; 164(2): 543 - 555.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
R. Sitcheran, P. C. Cogswell, and A. S. Baldwin Jr.
NF-{kappa}B mediates inhibition of mesenchymal cell differentiation through a posttranscriptional gene silencing mechanism
Genes & Dev., October 1, 2003; 17(19): 2368 - 2373.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
A. Moralez, W. H. Busby Jr., and D. Clemmons
Control of Insulin-Like Growth Factor Binding Protein-5 Protease Synthesis and Secretion by Human Fibroblasts and Porcine Aortic Smooth Muscle Cells
Endocrinology, June 1, 2003; 144(6): 2489 - 2495.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
J. Pfeilschifter, R. Koditz, M. Pfohl, and H. Schatz
Changes in Proinflammatory Cytokine Activity after Menopause
Endocr. Rev., February 1, 2002; 23(1): 90 - 119.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. Kurokouchi, C. R. Jacobs, and H. J. Donahue
Oscillating Fluid Flow Inhibits TNF-alpha -induced NF-kappa B Activation via an Ikappa B Kinase Pathway in Osteoblast-like UMR106 Cells
J. Biol. Chem., April 13, 2001; 276(16): 13499 - 13504.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
L. Gilbert, X. He, P. Farmer, J. Rubin, H. Drissi, A. J. van Wijnen, J. B. Lian, G. S. Stein, and M. S. Nanes
Expression of the Osteoblast Differentiation Factor RUNX2 (Cbfa1/AML3/Pebp2alpha A) Is Inhibited by Tumor Necrosis Factor-alpha
J. Biol. Chem., January 18, 2002; 277(4): 2695 - 2701.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2000 by The Endocrine Society